SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-10-004147
Filing Date
2010-07-22
Accepted
2010-07-21 17:56:12
Documents
2
Period of Report
2010-07-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. 8-K a6368678.htm 8-K 14954
2 EXHIBIT 99.1 a6368678ex99_1.htm EX-99.1 5478
  Complete submission text file 0001157523-10-004147.txt   22015
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 10963112
SIC: 2836 Biological Products, (No Diagnostic Substances)